Elliott City, MD, United States of America

Arti N Santhanam

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arti N Santhanam: Innovator in Therapeutic Nanoparticles

Introduction

Arti N Santhanam is a prominent inventor based in Elliott City, MD (US). She has made significant contributions to the field of therapeutic nanoparticles, particularly in the development of innovative RNA/DNA chimeric nanoparticles. Her work has the potential to advance medical treatments and improve patient outcomes.

Latest Patents

Arti N Santhanam holds 1 patent for her invention titled "Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles." This patent describes pairs of DNA/RNA hybrids where the DNA molecules possess complementary toehold sequences. These sequences promote the re-association of the RNA/DNA nanoparticles when mixed, resulting in the formation of RNA/RNA duplexes that function as small interfering RNAs (siRNAs). This innovative approach could lead to breakthroughs in therapeutic applications.

Career Highlights

Throughout her career, Arti has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of California. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Arti N Santhanam has collaborated with notable colleagues, including Bruce Allen Shapiro and Kirill Andreevich Afonin. These partnerships have enriched her research and expanded the impact of her innovations in therapeutic nanoparticles.

Conclusion

Arti N Santhanam is a trailblazer in the field of therapeutic nanoparticles, with her innovative work paving the way for future advancements in medical treatments. Her contributions are invaluable to the scientific community and hold promise for improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…